Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce

CONCLUSIONS: Based on the current data and clinician input, a range of nutraceuticals and phytoceuticals were given either a supportive recommendation or a provisional recommendation across a range of various psychiatric disorders. However several had only a weak endorsement for potential use; for a few it was not possible to reach a clear recommendation direction, largely due to mixed study findings; while some other agents showed no obvious therapeutic benefit and were clearly not recommended for use. It is the intention of these guidelines to inform psychiatric/medical, and health professional practice globally.PMID:35311615 | DOI:10.1080/15622975.2021.2013041

Source: The World Journal of Biological Psychiatry - March 21, 2022 Category: Psychiatry Authors: Jerome Sarris Arun Ravindran Lakshmi N Yatham Wolfgang Marx Julia J Rucklidge Roger S McIntyre Shahin Akhondzadeh Francesco Benedetti Constanza Caneo Holger Cramer Lachlan Cribb Michael de Manincor Olivia Dean Andrea Camaz Deslandes Marlene P Freeman Bang Source Type: research